Device
MiSight 1 Day
MiSight 1 Day is a medical device with 4 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
3(75%)
Results Posted
100%(1 trials)
Phase Distribution
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Completed(1)
Detailed Status
Recruiting2
Active, not recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
3
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
active_not_recruiting125%
recruiting250%
completed125%
Recent Activity
3 active trials
Showing 4 of 4
recruitingnot_applicable
MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms
NCT05285553
recruitingnot_applicable
MiSight 1 Day Safety Post-Approval Study
NCT05285527
completed
Visual Performance of Soft Contact Lenses With Myopia Control Optics
NCT05141448
active_not_recruitingnot_applicable
Comparison of MiSight 1-Day and Acuvue Oasys for Presbyopia in Myopic Children
NCT06887920
Clinical Trials (4)
Showing 4 of 4 trials
NCT05285553Not Applicable
MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms
NCT05285527Not Applicable
MiSight 1 Day Safety Post-Approval Study
NCT05141448
Visual Performance of Soft Contact Lenses With Myopia Control Optics
NCT06887920Not Applicable
Comparison of MiSight 1-Day and Acuvue Oasys for Presbyopia in Myopic Children
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4